MedTrace Logo

Hydrodissection as a Treatment for Carpal Tunnel Syndrome

NCT03427983 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2019-08-14

No results posted yet for this study

Summary

This is a pilot study designed to acquire data on the added value of hydrodissection when using a corticosteroid injection as a treatment for patients with carpal tunnel syndrome. Hydrodissection is part of a standard clinical care injection under ultrasound guidance in which the fluid is used to separate the nerve from surrounding structures.

Conditions

  • Carpal Tunnel Syndrome

Interventions

PROCEDURE

Hydrodissection

Additional 3cc's of saline is used to establish an increase in hydrodissection during routine treatment.

PROCEDURE

Regular Injection

Corticosteroid and lidocaine injection without additional saline is used as routine treatment.

Sponsors & Collaborators

Principal Investigators

  • Peter C Amadio, MD · Mayo Clinic

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
21 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-03-08
Primary Completion
2019-07-31
Completion
2019-07-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03427983 on ClinicalTrials.gov